A 7.5 mg<unk>  tablet.<unk>  is used for the short-term treatment of insomnia where sleep initiation or sleep maintenance are prominent symptoms. Long-term use is not recommended, as tolerance, dependence, and addiction can occur. One low-quality study found that<unk>  is ineffective in improving sleep quality or increasing sleep time in shift workers, and more research in this area has been recommended. Cognitive behavioral therapy has been found to be superior to<unk>  in the treatment of insomnia and has been found to have lasting effects on sleep quality for at least a year after therapy. Specific populations Elderly<unk> , similar to other benzodiazepines and nonbenzodiazepine hypnotic drugs, causes impairments in body balance and standing steadiness in individuals who wake up at night or the next morning. Falls and hip fractures are frequently reported. The combination with alcohol consumption increases these impairments. Partial, but incomplete tolerance develops to these impairments.<unk>  increases postural sway and increases the number of falls in older people, as well as cognitive side effects. Falls are a significant cause of death in older people. An extensive review of the medical literature regarding the management of insomnia and the elderly found that considerable evidence of the effectiveness and lasting benefits of nondrug treatments for insomnia exist. Compared with the benzodiazepines, the nonbenzodiazepine sedative-hypnotics, such as<unk> , offer few if any advantages in efficacy or tolerability in elderly persons. Newer agents such as the melatonin receptor agonists may be more suitable and effective for the management of chronic insomnia in elderly people. Long-term use of sedative-hypnotics for insomnia lacks an evidence base and is discouraged for reasons that include concerns about such potential adverse drug effects as cognitive impairment (anterograde amnesia), daytime sedation, motor incoordination, and increased risk of motor vehicle accidents and falls. In addition, the effectiveness and safety of long-term use of nonbenzodiazepine hypnotic drugs remains to be determined. Liver disease Patients with liver disease eliminate<unk>  much more slowly than normal patients and in addition experience exaggerated pharmacological effects of the drug.
Zopiclone
Eszopiclone
Chloropicrin
Flumetasone
Budesonide
Clobetasone
Mibolerone
Fluticasone furoate